SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-05-103001
Filing Date
2005-05-10
Accepted
2005-05-10 17:20:07
Documents
8
Period of Report
2005-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 519650
2 AMENDMENT NO. 4 TO LICENSE AND OPTION AGREEMENT DATED MARCH 31, 2005 dex101.htm EX-10.1 24806
3 CO-PROMOTION AGREEMENT DATED APRIL 11, 2005 dex102.htm EX-10.2 459839
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 dex311.htm EX-31.1 10330
5 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 dex312.htm EX-31.2 10369
6 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 906 dex321.htm EX-32.1 3956
7 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 906 dex322.htm EX-32.2 3985
8 GRAPHIC g40539img001.jpg GRAPHIC 7856
  Complete submission text file 0001193125-05-103001.txt   1045556
Mailing Address 1000 WINTER STREET SUITE 2200 WALTHAM MA 02451
Business Address 1000 WINTER STREET SUITE 2200 WALTHAM MA 02451 7813982300
OSCIENT PHARMACEUTICALS CORP (Filer) CIK: 0000356830 (see all company filings)

IRS No.: 042297484 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-10824 | Film No.: 05817949
SIC: 2835 In Vitro & In Vivo Diagnostic Substances